Early development and potency restriction
Development starts from a single cell that divides and differentiates to generate all cell types of the adult body. In vertebrates, the early cell divisions are dedicated to the generation of multiple, equi-potent blastomeres. Here, we consider whether this state can be perpetuated in mammalian cell culture and what defines this state transcriptionally.
In Eutherian mammals, the early blastomeres progressively differentiate into three lineages: the two extraembryonic lineages, the trophoblast and primitive endoderm (PE), and a single embryonic lineage, the epiblast (Epi). The Epi will give rise to both the somatic and germ lineages. We will refer to these lineages arising during preimplantation development as the three principal lineages. In the mouse, the first specialization event occurs at the 16-cell stage following a morphological change known as compaction. During compaction, adherens and tight junctions form between adjacent blastomeres, leading to an increase in the cell-cell contact area. At this stage, the polarized outer cells of the embryo begin to differentiate towards trophoblast while the inner cells, or inner cell mass (ICM), start to explore the lineage programmes of the Epi and the PE. Immediately following compaction, a fluid-filled cavity begins to form in the embryo and the ICM cells become localized to one side of the cavity, forming the blastocyst (figure 1a). The ICM resolves with time into a salt and pepper distribution of cells that have initiated lineage specific Epi and PE gene expression. As the blastocyst continues to expand, these PE and Epi precursors morphologically segregate so that the PE cells line the floor of the blastocoel cavity. The Epi is now specified and will go on to generate the majority of adult lineages derived from the three germ layers, the definitive endoderm, ectoderm and mesoderm, as well as the germline.
While the morphological segregation of the trophoblast from the ICM happens at the 16-cell stage, it is not clear when lineage restriction or commitment of these two populations occurs. Single blastomeres, from as late as the 32-cell stage, can generate entire mice in tetraploid aggregations [1] . Additionally, when ICM cells from the early blastocyst are aggregated with morulae, 32% can still contribute to the trophoblast and isolated aggregated ICMs can implant and form normal egg cylinders [2] , indicating that they retain the capacity to generate functional extraembryonic tissues (figure 1a). From these experiments, it was observed that the ICM loses the capacity to make trophoblast when it expands to more than 16-19 cells [2] . Similar observations were made based on the in vitro differentiation of ICM cells into trophoblast [3] [4] [5] . As well as ICM cells, the outer trophoblast cells also retain functional plasticity after morphological & 2014 The Author(s) Published by the Royal Society. All rights reserved. Figure 1 . Schematic overview of transcription factor expression and cellular potency in mouse ES cells and preimplantation embryos. (a) Illustration of mouse development between embryonic day (E) 0.5 and 4.5. The main events occurring at each stage are listed. After fertilization, the oocyte extrudes the second polar body (2PB) and begins to undergo reductive cleavage divisions. At the 8-cell stage, many lineage-associated transcription factors, including NANOG (epiblast, Epi), GATA6 (primitive endoderm, PE) and CDX2 (trophoblast, TE), are expressed and are initially coexpressed within the same cells. After this point, the embryo undergoes compaction where adherens junctions form between cells, followed by tight junction formation. After compaction, blastomeres acquire apical polarity and subsequent asymmetric divisions generate outer polar and inner apolar cells. At the 16-cell stage (E3.0), outer and inner cells are already biased towards the extraembryonic TE and inner cell mass (ICM) lineages, respectively. However, inner and outer cells still retain the capacity to contribute to the alternative lineage in aggregation chimaeras. At E3.5, cavitation occurs generating the early blastocyst with a layer of outer TE cells and an ICM consisting of cells that coexpress NANOG and GATA6. At this point, the TE appears to be restricted in its fate, although some cells of the ICM still maintain the capacity to generate trophoblast cells. At the mid-blastocyst stage (E4.0), the expression of NANOG and GATA6 has resolved to form a heterogeneous mixture of Epi and PE precursors. Half a day later these precursor populations have differentiated and segregated into distinct layers, the inner Epi and the PE, now lining the blastocoel cavity. These 2-cell state (2C) populations are now functionally restricted to their respective lineages. While these populations are restricted, NANOG and GATA6 continue to be expressed in a few trophoblast cells as late as E4.5. At the late blastocyst stage, just prior to implantation, the ICM tilts with the direction of the tilt being a predictor of the future anteriorposterior axis. Red asterisks mark the embryonic stages from which ES cells can be derived. Cell lines have also been derived from the 1-to 8-cell embryo, although these have not been functionally tested. (b) ES cell cultures are heterogeneous in standard serum/LIF conditions. One population of cells expresses the Epi marker NANOG (red cells), while mutually exclusive populations of cells transcribe the mRNA of the extraembryonic marker Hhex and 2C-associated genes. It is unclear whether these populations are overlapping in these conditions. In 2i/LIF cultures, expression of the NANOG protein is fairly homogeneous and co-localizes with expression of Hhex mRNA. 2C-associated genes are also enriched in the Hhex þ cells although there may also be a distinct 2C population that does not express NANOG protein. [7] . The timing of Epi and PE commitment is equally fluid. It has recently been shown that PE precursors retain a higher level of plasticity than their Epi-fated counterparts [8] . This conclusion was based on using embryos containing a transgenic Pdgfra-GFP reporter that marks PE precursor cells. At the early blastocyst stage, a high proportion of both cell types contributed to multiple tissues. The PE precursors (Pdgfra-GFP þ ) contributed, almost equally efficiently, to trophoblast (30%), PE (44%) and Epi (26%), whereas Epi precursors (Pdgfra-GFP 2 ) were less flexible, contributing significantly to only Epi (57%) and trophoblast (40%) but not PE (3%). However, unlike the trophoblast and ICM, once the PE is morphologically segregated from the Epi, the two-cell types lose their potential to make other lineages (figure 1a).
Embryonic stem cells and pluripotency
Embryonic stem (ES) cells are karyotypically normal cell lines typically derived from the ICM of the preimplantation embryo. However, it is also possible to derive ES cells from the earlier 8-cell morula stage (figure 1a). ES cells express markers found in the ICM including the transcription factors Oct4 and Nanog, and hence are thought to resemble the blastocyst cells from which they are derived. Remarkably, ES cells maintain the capacity to contribute to normal development when re-introduced into host embryos after prolonged ex vivo culture and can even generate an entire mouse when introduced into tetraploid embryos. ES cells are therefore referred to as 'pluripotent', able to make all the somatic lineages and the germ cells, but not the extraembryonic lineages, although it has long been known that, in vitro at least, ES cells can make extraembryonic PE [9] . As the functional properties of ES cells can be maintained indefinitely in culture, they are also said to be self-renewing.
ES cells can be cultured under a variety of conditions. Originally, they were grown on feeders in the presence of serum. The feeders provided the cytokine leukaemia inhibitory factor (LIF) [10] and the serum contained bone morphogenetic protein 4 (BMP4) [11] . Consequently, ES cells can now be cultured in defined conditions with LIF and BMP4. Cells grown under these conditions are heterogeneous with respect to Epi and PE markers, but are thought to represent the early Epi as they have a similar potency in chimaera experiments. It would therefore appear that ES cell pluripotency is not a property of the entire culture, but of the fraction of cells expressing early Epi markers that are able efficiently to contribute to the Epi in chimaeras. The homogeneity of Epi markers can be improved by the addition of two small molecule inhibitors of GSK3-b and MEK to ES cell cultures, so-called '2i medium'. These 2i-cultured ES cells are said to represent a naive pluripotent state. A second pluripotent cell type has also been identified and is characteristic of a later stage of postimplantation development. These cells are known as epiblast stem cells (EpiSCs) and, although these cells cannot contribute to chimaeras in the classical sense [12] , they can generate all somatic lineages and germ cells when transplanted to later stage embryos [13] . EpiSCs are maintained in Activin and fibroblast growth factor (FGF) and appear similar to cells in the primitive streak of the early gastrulation stage embryo [14] . While naive cells have been derived in both mouse and rat, they have only recently been characterized in human [15] [16] [17] . Most human ES cell lines represent primed pluripotent cells.
Pluripotent versus totipotent
Cells of the developing embryo and also ES cells in vitro can be classified according to their functional potential. The single-cell zygote is described as 'totipotent' as its progeny give rise to all cells of the embryo proper as well as the extraembryonic tissues, derived from the trophoblast and PE lineages. However, if we consider the zygote as the gold standard for totipotency, it tells us nothing about the functional potency of individual cells of the embryo during subsequent cell divisions and lineage specification. To distinguish between developmental fate and intrinsic potency, we define totipotency as the capacity of a single cell and its descendants to colonize all three of the principal lineages. As discussed above, while the fate of a cell's descendants becomes progressively more restricted, they could retain the capacity to give rise to all lineages when challenged by introduction into a new host embryo. Embryonic cells retain this totipotent capacity in early blastocyst stages [8] , while in similar experiments, ES cells appear restricted to the embryonic lineages and are therefore referred to as pluripotent.
As ES cells have become an important tool for the study of developmental biology, numerous methods have been developed to assess their functional potency. For example, ES cells can be differentiated in vitro to specific lineages as well as in vivo by injection into adult mice to form tumours known as teratomas. Teratomas comprise a mix of cell types from all germ layers and often contain an undifferentiated, malignant cell type called embryonic carcinoma cells [18] . Although the cell types within these tumours are disorganized, they contain derivatives of all three germ layers and hence can be said to mimic normal development. The assays discussed above involve differentiation outside of the endogenous embryonic context, but the most robust assessment of ES cell potency involves the re-introduction of a genetically labelled ES cell line into host embryos. This can be done by aggregating ES cells with morulae or by injecting cells into either morulae or blastocysts. On the basis of the majority of studies, the descendants of ES cells can contribute to all lineages except extraembryonic cell types.
To distinguish pluripotent ES cells from cells that are able to generate all the principal lineages required for mammalian development, we invoke the term 'totipotent'. It has been argued that only a fertilized egg that generates a complete, functioning organism and associated structures can be referred to as totipotent [19] . However, this definition ignores the assays used as standards in the field to characterize potency and therefore makes a distinction between the definition of totipotency and that of pluripotency. By the standard of this definition, no ES cell would be pluripotent unless it could be rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 369: 20130549
shown to generate the entire adult mouse from a single cell. While a group of ES cells can form an entire mouse in tetraploid aggregations [20] , these cells have the environment of the blastocyst to provide patterning cues. Moreover, when single ES cells were injected into tetraploid embryos, only one viable mouse was generated out of 192 injected embryos [21] . Additionally, data suggest that, even in tetraploid aggregation, ES cells do not make up the entirety of every organ [22] .
The outcome of functional assessments of cell potency are also inherently limited and biased by the experimental design, making it difficult to distinguish between the intrinsic properties of cells and the effect of external factors. The environment that ES cells are introduced into has been shown to affect the experimental outcome. For example, ES cells contribute more efficiently to embryos in morula aggregations than in blastocyst injections [23] , frequently generating 100% ES cellderived mice [24] . The apparent functional potency observed is therefore probably a product of a cell's capacity to survive in a particular environment as well as its inherent properties. It has previously been shown that only 1-2 out of 10 -15 ES cells injected into an embryo are able to contribute to further development [21] , suggesting that introducing too many ES cells could interfere with their own capacity to stably integrate into embryonic development. Comparison of the capacity of ES cells to proliferate when re-introduced into embryos also supports this notion. When a single ES cell is introduced into a morula stage embryo, it undergoes more cell divisions than ES cells introduced as a group [25] . As a result, ES cell potency is also a function of the nature of the cells surrounding it.
Totipotent cells
In the last few years, it has become increasingly apparent that ES cell cultures do not represent a single defined cell type. ES cell cultures are heterogeneous and contain cells that approximate the lineages of the blastocyst, with individual cells that are primed for both Epi and extraembryonic PE differentiation [26] [27] [28] (figure 1b). As a result, when ES cells are challenged to differentiate either in vivo or in vitro, some cells exhibit only Epi potential, while others can contribute to extraembryonic lineages [26] . As most functional assays for potency are performed using groups of cells, pluripotency could be a consequence of a competition between the Epi-and PE-like cells, with the Epi-like cells being able to proliferate and incorporate into the blastocyst more efficiently. However, when the activity of specific sub-populations of ES cells is assessed, a number of studies suggest that ES cells may also contain a population of cells that have yet to commit to pluripotency.
In addition to the genes normally associated with early blastocyst development, referred to as the pluripotency genes, ES cells also express genes specific to earlier developmental stages prior to fate restrictions. Zscan4, a telomere maintenance gene specifically expressed at the 2-cell (2C) stage, is expressed in around 5% of ES cells [29] . Although Zscan4 is expressed in only a small population of cells at any given time, almost all cells express this gene at some point during prolonged passaging. Moreover, Zscan4 expression was found to be necessary for ES cells to maintain long-term proliferation [30] . The expression of Zscan4 was also correlated with increased contribution to the embryo in tetraploid aggregations. A similar population expressing Zscan4 was identified based on the expression of murine endogenous retrovirus with leucine tRNA primer (MuERV-L) elements [31] . Mouse embryos at the 2C stage express a number of MuERV-L retroviral elements and these elements drive the expression of more than 100 2C-specific genes. A fluorescent reporter driven by a canonical MuERV-L enabled the isolation of a population of ES cells that express 2C transcripts (figure 1b). When this population was isolated and assessed in chimaera assays, its descendants were found in both embryonic and extraembryonic lineages [31] .
Although the cases above refer to ES cells cultured under standard conditions, high levels of chimaerism and germline transmission rates can be achieved by culturing ES cells in 2i medium with LIF (2i/LIF) [32] . These conditions also make ES cell derivation possible from normally recalcitrant mouse strains [33] and rat embryos [34] , and most recently a variant of 2i has been used to derive naive human ES cells [15] [16] [17] . In 2i conditions, ES cells are also heterogeneous and include a significant fraction of cells that can be prospectively isolated based on the expression of the extraembryonic transcription factor Hhex [35] (figure 1b). This fraction of cells exhibits a bias during in vitro differentiation towards the extraembryonic lineages, but in vivo can contribute effectively to all three principal lineages, Epi, trophoblast and PE, and hence is totipotent [35] .
Pluripotent cell lines can also be produced through reprogramming of somatic cells by ectopically expressing the ES cell transcription factors Oct4, Sox2, Klf4 and c-Myc (OSKM) to make induced pluripotent stem (iPS) cells [36] . Recently, it was observed that the in vivo induction of OSKM in adult mice generated iPS cells that could differentiate towards embryonic and extraembryonic lineages both in vitro and in vivo [37] . These iPS cells have a transcriptional profile that correlates more strongly with ES cells than iPS cells generated by standard in vitro induction of the four transcription factors. Intriguingly, although these in vivo iPS cells did not show an upregulation of 2C genes, also associated with trophoblast potential, they did show an upregulation of a number of genes associated with the morula stage embryo.
No single-cell experiments were carried out with either the 2C-like populations or the in vivo-derived iPS cells, and hence it is not possible to distinguish between the presence of totipotent single cells or mixed populations with distinct functional potentials. However, it has been shown that single ES cells, expressing the extraembryonic endoderm marker Hhex, can contribute both to embryonic and extraembryonic lineages after culture in 2i/LIF medium [35] . Single cells were able to differentiate into embryonic and extraembryonic lineages both in vitro and in vivo, and hence represent a totipotent cell type.
Gene regulatory networks and totipotency
During the first few cleavage divisions of mouse development, the early blastomeres coexpress determinants of all three principal lineages [38] . At the 16-cell stage, following compaction, the trophoblast transcription factor CDX2 is upregulated in outer polarized cells, and downregulated in the inner cells [38, 39] . The ICM transcription factor OCT4 starts to become downregulated in outside cells at the blastocyst stage. The Epi and PE transcription factors NANOG and GATA6 continue to be expressed heterogeneously in the outside cells well into the blastocyst stage [35, 38] while, in the early ICM, they are initially coexpressed and their expression gradually resolves over time (figure 1a). By embryonic day (E) 3.5, PE and Epi precursors can be sorted based on the rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 369: 20130549 mutually exclusive expression of these two transcription factors [40, 41] . These cells then physically sort based on a variety of cell behaviours, including differential adhesion, apoptosis and downregulation of the PE programme in inside cells [41] , resulting in the segregation of Epi and PE layers by E4.5. In addition to Nanog, a number of other Epi markers such as Rex1 [42] are expressed in early blastomeres and are later restricted to the pluripotent Epi. These transcription factors are also expressed in ES cells and have been referred to as the pluripotency network.
On the basis of the progression of lineage segregation in vivo, totipotent cells would seem to be those that coexpress embryonic and extraembryonic determinants. The expression of these canonical lineage markers begins with OCT4, GATA6, NANOG and CDX2, all apparent by the 8-cell stage [38, 41] . Many of these transcription factors continue to be coexpressed into blastocyst stages ( figure 1a) .
In mouse, zygotic transcription begins at the 2C stage and, as alluded to above, there is a class of transcripts associated with endogenous retroviral LTRs expressed prior to the canonical pluripotency network [43] . While the expression of these genes is correlated with totipotency in ES cells, it would appear that 2C ES cells also express the RNA for pluripotency factors such as Nanog and Oct4 [31] . The overexpression of Zscan4 did not increase the expression of 2C genes, suggesting that it is a marker rather than a regulator of this population [44] . Overexpression of Tbx3, a gene enriched in the 2C population, increased the expression of 2C genes; however, it did not increase the size of the population indicating that it is not sufficient to promote a 2C state [44] .
When the pluripotency-associated gene Rex1 is knocked down in ES cells, MuERV-L genes are upregulated although there is no significant effect on the expression of pluripotency markers [45] . Additionally, when Rex1 was knocked down in preimplantation embryos, MuERV-L was ectopically expressed at the morula stage [45] and, conversely, overexpression of Rex1 decreased the levels of Zscan4 by threefold [46] . Endogenous retroviral genes expressed at the blastocyst stage of development were also not affected by Rex1 depletion suggesting that Rex1 may specifically act upon 2C retroviral element-containing genes.
The Hhex positive totipotent cells, observed in 2i culture, coexpress embryonic and extraembryonic markers [35, 47] . However, the cells are not identical to those observed in vivo as, while they coexpress the mRNA encoding factors promoting embryonic and extraembryonic lineages, the translation of extraembryonic transcription factors appears blocked (figure 1b). Hhex-expressing ES cells in 2i cultures coexpress embryonic markers such as Nanog, Oct4 and Sox2 and extraembryonic markers such as Eomes, Gata3, Serpine2 and Tcfap2a, although extraembryonic proteins are not observed [35] . A totipotent state may therefore be maintained via a post-transcriptional block of extraembryonic lineagespecific genes. Consistent with this idea, it has recently been shown that, in the 2C state, there are higher levels of Eif1a-like genes that result in a global repression of de novo protein synthesis [48] . The presence of high levels of mRNA for these genes may mean that cells are poised for differentiation, while at the same time the activation of downstream differentiation programmes is blocked by regulation at the protein level.
The coexpression of embryonic and extraembryonic genes is usually presented as undergoing resolution in an ordered fashion, i.e. coexpression of embryonic and extraembryonic genes, followed by mutually exclusive expression and, finally, morphological lineage segregation. However, even after morphological segregation of the trophoblast and ICM, outer trophoblast cells continue to express both CDX2 and OCT4 protein for a significant period of time [38] . Moreover, NANOG and GATA6 can be found in a few trophoblast cells as late as E4.5 [35] (figure 1a). Perhaps this prolonged coexpression implies that totipotent cells could exist as late in mammalian development as implantation.
Nevertheless, although a totipotent state appears to be characterized by the coexpression of transcription factors associated with different lineages, the expression of these factors themselves may not be the principle determinant of totipotency, but rather a signature of this state. Thus mouse mutants of many of the genes that are coexpressed at early stages, such as Oct4, Nanog and Gata6, can develop past these early time points and can undergo some aspects of lineage specification [49] [50] [51] [52] [53] . Hence, individually, these factors may not be explicitly required for sustaining a totipotent state.
Chromatin states and totipotency
The coexpression of multiple lineage-specific transcription factors is probably associated with the open chromatin structure observed during the early stages of preimplantation development. During these stages, the DNA of blastomeres exists in a hypomethylated state that becomes increasingly methylated during differentiation [54] . This hypomethylated state allows the expression of the endogenous retroviral elements associated with 2C potency. These elements are later repressed, in part, by DNA methylation. Cell types that are able to selfrenew and show a wide differentiation capacity also exhibit DNA hypomethylation, including ES cells, cancer cells and primordial germ cells (PGCs) [55, 56] . The PGC-associated gene Prdm14 maintains potency in part by repressing DNA methylation enzymes [56] . ES cell cultures maintained in 2i/ LIF, which contain a totipotent subpopulation of cells, are hypomethylated [57] [58] [59] and exhibit reduced levels of the repressive chromatin mark H3K27me3 [59] . Similarly, in 2C-like ES cells, MuERV-L elements are hypomethylated and exhibit an increase in histone marks associated with active transcription, such as H3K4 methylation and H3 and H4 acetylation [31] . Furthermore, when Tbx3, a transcription factor promoting the 2C state, is overexpressed, expression of the DNA methyltransferase Dnmt3b is inhibited leading to a reduction in 5-methylcytosine (5mc) levels [44] .
During early embryonic cleavage stages, many chromatin modifiers, co-activators and repressors are expressed in discrete and highly dynamic expression patterns [60] . At the 8-cell stage a unique set of these regulators are expressed, including the demethylases Kdm5a, Kdm6a and Dnmt3l, and these factors are also expressed in later trophoblast cells. In the blastocyst itself, it is difficult to assign specific chromatin modifiers to any one of the three principal lineages, although the ICM expresses higher levels of Prdm14 and the trophoblast expresses higher levels of Dnmt3l and Dnmt3b. The correlation of these chromatin modifiers to in vitro totipotent populations has not yet been explored in detail, although it has been shown that the 2C-like population is increased in ES cell lines containing mutations in the histone modifiers Kdm1a, Kap1 and G9a [31] .
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In ES cells, Polycomb complexes catalyse the addition of the repressive H3K27me3 histone modification to the promoters of developmentally important genes [61] . In Polycomb mutant cells, the expression of these genes is elevated; hence it is thought that Polycomb complexes maintain a pluripotent state by supressing differentiation-associated gene expression [61] . While some Polycomb targets in ES cells are germ layer determinants, a large number of these are expressed in the extraembryonic lineages and the expression of others has not been explored during preimplantation development. Hence, an alternative interpretation is that Polycomb maintains pluripotency by restricting totipotency or extraembryonic gene transcription. It has recently been shown that, in cells exhibiting global hypomethylation, Polycomb complexes can be titrated away from promoters to bind to intergenic regions [62] . The net effect of this would be the de-repression of extraembryonic promoters normally bound by Polycomb complexes, allowing the upregulation of trophoblast and PE genes.
In addition to affecting transcription, the hypomethylated state of early embryos and ES cells facilitates the elongation of telomeres. Telomeres are regions of repetitive DNA at the end of chromosomes that help to maintain genomic stability. In somatic cells telomeric regions are rich in chromatin modifications associated with a heterochromatic state, including H3K9me3, H4K20me3 and DNA hypermethylation [63] [64] [65] [66] . However, in ES cells and early embryos, the chromatin structure of telomeres is more open. ES cells additionally have high activity of telomerase, the enzyme involved in de novo generation of telomeres, which, together with the accessibility of telomeric regions, means that ES cells have longer telomeres than somatic cells. The length of telomeres has been directly associated with functional potency as ES cells with short telomeres show a decreased functional potency in chimaera and teratomas assays [67] . Both Wnt signalling and the pluripotency-associated factor Klf4 regulate the expression of telomerase reverse transcriptase (Tert), a catalytic subunit of telomerase. Knockdown of Klf4 leads to differentiation of ES cells, alongside a decrease in Tert expression. The Klf4 differentiation phenotype can be rescued by overexpression of Tert [68] . Additionally, the 2C-associated gene Zscan4 plays a role in telomere maintenance and knockdown of Zscan4 results in shortened telomeres and genomic instability [30] .
While a number of these chromatin and DNA modifications correlate with the functional potency of ES cells, it appears that they are not sufficient for the control of potency. Some of the changes discussed above correlate with cell states, but may not have a role in their establishment. For example, genomic regions that are differentially methylated between ES and trophoblast stem (TS) cells are also differentially methylated when trophoblast and Epi from E6.5 embryos are compared, but remain demethylated in the TE and ICM of the blastocyst [69] , suggesting that lineage-specific methylation is a consequence of lineage choice rather than a cause.
Totipotency and proliferation
Another characteristic that may define totipotency is the capacity of a cell to undergo rapid, self-renewing cell cycles once introduced into an embryo. A 'totipotent' cell could be a single cell that, for example, has a shorter cell cycle and could produce a greater number of progeny before responding to differentiation-inducing signals. The progeny of this cell would therefore colonize the embryo to a greater extent than a cell with slower divisions. This is consistent with the finding that ES cell clones with a higher proliferation rate generate a greater number of chimaeras than those that proliferate more slowly [21] . The first two cleavage divisions of the mouse embryo last approximately 20 h while the third and fourth divisions last approximately 11 h [70] .The cell cycle of an ES cell is approximately 10-16 h, but the relative length of the cycle once ES cells are introduced into a blastocyst, and the extent to which these divisions are self-renewing, have not been determined.
Signalling, lineage restriction and the gene regulatory network
FGF signalling is implicated in the segregation of three principal early lineages. Epi precursors produce FGF4 and this in turn supports proliferation of the trophoblast [71] . Exogenous FGF is also required to maintain TS cells in vitro [72] . Additionally, FGF signalling is required for the segregation of PE and Epi in vivo [40, 71, 73] , although the initial expression of the endoderm transcription factor GATA6 is independent of FGF signalling [74, 75] . However, this early GATA6 expression is in cells that also express NANOG, and FGF signalling appears essential for the downregulation of NANOG in NANOG/GATA6 coexpressing cells and the subsequent initiation of the downstream endodermal transcription programme. This is consistent with evidence showing that FGF regulates GATA6 expression both directly and indirectly through suppression of NANOG [76] . The FGF-dependent segregation of PE and Epi in vivo is dependent on signalling through MEK and ERK downstream of the receptor. As 2i medium contains an MEK inhibitor, it is therefore not surprising that a significant proportion of cells grown in 2i/LIF, marked by NANOG, PE and trophoblast transcription, have not become committed, and are totipotent [35] . Similarly, when blastocysts are cultured ex vivo in 2i/LIF, expression of PE transcription is maintained in a subset of NANOG positive cells, arguing that both in vivo and in vitro, the block to FGF signalling inhibits lineage segregation and sustains totipotency.
In addition to the inhibition of MEK, 2i medium generally contains two other factors, the GSKb inhibitor Chiron and the cytokine LIF [32] . The inhibition of GSK3b can also lead to the induction of trophoblast gene expression in rat ES cells [77] , and therefore may contribute to the proportion of ES cell cultures that express RNA encoding extraembryonic determinants.
The cytokine LIF signals through the JAK/STAT pathway to maintain self-renewal in ES cells. Interestingly, STAT3 targets include both members of the canonical pluripotency network as well as a similar number of targets that are lineage regulators, including transcription factors known to promote both trophoblast and PE differentiation. Interestingly, Stat3 null ES cells grown in 2i/LIF express lower levels of lineage-associated genes, but only show a decrease in the expression of one member of the pluripotency network, Klf4 [35] . Moreover, LIF stimulates the expansion of ES cells expressing the endoderm marker Hhex, but not Nanog, in both standard serum conditions and 2i [35] . While ES cells in 2i can self-renew without LIF, LIF enhances their clonogenicity and the capacity of single ES cells to differentiate into all three principal lineages both in vivo and in vitro [32, 35] . The enhanced clonogenicity stimulated by LIF could explain the totipotent character of a fraction of 2i/LIF ES cells. This activity of LIF in promoting rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 369: 20130549 totipotency correlates with its ability to induce both extraembryonic and 2C-associated transcription within a 2i culture otherwise homogeneous for NANOG [35, 78] .
Conclusion
If we are to judge totipotency based on the coexpression of embryonic and extraembryonic genes, as reflected in 2i/LIF totipotent ES cells or in the early mammalian embryo, then there is evidence for a potential totipotent state in both rat and human ES cells. The generation of robust rat ES cells was only possible with culture in 2i/LIF and it was recently reported that these conditions support the expression of trophoblast markers such as CDX2 [77] .
Naive human ES cells have recently been derived with variations on 2i that include a range of other inhibitors and active signalling components including LIF [15] [16] [17] . Interestingly, while naive human cells cannot be readily tested for functional potency in vivo, gene expression analysis suggests that a significant proportion of cells within these cultures coexpress NANOG and extraembryonic transcription factors such as GATA6 protein and TEAD4 RNA, as do the inner cells of the late morula. Moreover, unlike the mouse model but like the totipotent cells of the late morula or early blastocyst, human naive ES cells coexpress GATA6 and NANOG protein in as much as 50% of the culture. As a result, it may be easier to maintain a true totipotent population in human models then has historically been possible in the mouse. Perhaps through a better understanding of the pathways used in generating these NANOG and GATA6 coexpressing human cells, we will come to understand how totipotency can be propagated and how it becomes restricted in vivo.
